Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherBasic Science (Animal or Phantoms)

Evaluation of (rac)-, (R)- and (S)-18F-OF-NB1 for imaging GluN2B subunit-containing N-methyl-D-aspartate receptors in non-human primates

Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul R. Emery, Hong Gao, Jim Ropchan, Ahmed Haider, Gilles Tamagnan, Richard E. Carson, Simon M. Ametamey and Yiyun Huang
Journal of Nuclear Medicine June 2022, jnumed.122.263977; DOI: https://doi.org/10.2967/jnumed.122.263977
Hazem Ahmed
1 Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hazem Ahmed
Ming-Qiang Zheng
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Smart
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanyi Fang
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Zhang
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul R. Emery
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Gao
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim Ropchan
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Haider
1 Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Tamagnan
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard E. Carson
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon M. Ametamey
1 Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiyun Huang
2 PET Center, Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Despite two decades of research, no GluN1/2B radioligand is yet clinically validated. Previously, we reported on (rac)-18F-OF-NB1 as a promising GluN1/2B PET probe in rodents, and its successful application for the visualization of GluN2B-containing N-methyl-D-aspartate receptors (NMDARs) in postmortem brain tissues of patients with amyotrophic lateral sclerosis. In the current work, we report on the in vivo characterization of (rac)-, (R)- and (S)-18F-OF-NB1 in non-human primates. Methods: PET scans were performed in rhesus monkeys. Plasma profiling was used to obtain the arterial input function. Regional brain time-activity curves (TACs) were generated and fitted with the one-tissue and two-tissue compartment models (1TCM and 2TCM) and the multilinear analysis-1 (MA1) method, and the corresponding regional volumes of distribution (VT) were calculated. Blocking studies with the GluN1/2B ligand Co 101244 (0.25 mg/kg) were performed for the enantiopure radiotracers. Receptor occupancy, non-specific volume of distribution, and regional binding potential (BPND) values were obtained. Potential off-target binding towards sigma-1 receptors (σ1Rs) was assessed for (S)-18F-OF-NB1 using the σ1R ligand FTC-146. Results: Free plasma fraction was moderate, ranging from 12% to 15%. All radiotracers showed high and heterogeneous brain uptake with highest levels in the cortex. (R)-18F-OF-NB1 showed the highest uptake and slowest washout kinetics out of all tracers. The 1TCM and MA1 method fitted the regional TACs well for all tracers and produced reliable regional VT values, which were higher for (R)- than (S)-18F-OF-NB1. Receptor occupancy by Co 101244 was 85% and 96% for (S)-18F-OF-NB1 and (R)-18F-OF-NB1, respectively. Pretreatment with FTC-146 at both a low (0.027 mg/kg) and high (0.125 mg/kg) dose led to similar reduction (48% and 49%, respectively) in specific binding of (S)-18F-OF-NB1. Further, pretreatment with both Co 101244 and FTC-146 did not result in further reduction of specific binding than Co 101244 alone in the same monkey (82% vs 81%, respectively). Regional BPND values ranged from 1.32 in the semiovale to 3.44 in the cingulate cortex for (S)-18F-OF-NB1. Conclusion: Both (R)- and (S)-18F-OF-NB1 exhibited high binding specificity to GluN2B subunit-containing NMDARs. The fast washout kinetics, good regional BPND values, and high plasma free fraction render (S)-18F-OF-NB1 an attractive radiotracer for clinical translation.

  • Animal Imaging
  • Neurology
  • PET
  • Brain PET Imaging
  • GluN2B subunit
  • NMDA
  • Neurodegeneration
  • Non-human Primates
  • Copyright © 2022 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (7)
Journal of Nuclear Medicine
Vol. 63, Issue 7
July 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of (rac)-, (R)- and (S)-18F-OF-NB1 for imaging GluN2B subunit-containing N-methyl-D-aspartate receptors in non-human primates
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of (rac)-, (R)- and (S)-18F-OF-NB1 for imaging GluN2B subunit-containing N-methyl-D-aspartate receptors in non-human primates
Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul R. Emery, Hong Gao, Jim Ropchan, Ahmed Haider, Gilles Tamagnan, Richard E. Carson, Simon M. Ametamey, Yiyun Huang
Journal of Nuclear Medicine Jun 2022, jnumed.122.263977; DOI: 10.2967/jnumed.122.263977

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of (rac)-, (R)- and (S)-18F-OF-NB1 for imaging GluN2B subunit-containing N-methyl-D-aspartate receptors in non-human primates
Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul R. Emery, Hong Gao, Jim Ropchan, Ahmed Haider, Gilles Tamagnan, Richard E. Carson, Simon M. Ametamey, Yiyun Huang
Journal of Nuclear Medicine Jun 2022, jnumed.122.263977; DOI: 10.2967/jnumed.122.263977
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Basic Science (Animal or Phantoms)

  • 18F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models
  • Improved tumor responses with sequential targeted alpha followed by IL2 immunocytokine therapies in treatment of CEA positive breast and colon tumors in CEA transgenic mice
  • 18F-FDG PET visualizes systemic STING agonist-induced lymphocyte activation in preclinical models
Show more Basic Science (Animal or Phantoms)

Basic (Neurology)

  • Single cell radiotracer allocation via immunomagentic sorting (scRadiotracing) to disentangle PET signals at cellular resolution
  • 11C-PiB and 124I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention
Show more Basic (Neurology)

Similar Articles

Keywords

  • Animal Imaging
  • neurology
  • PET
  • Brain PET Imaging
  • GluN2B subunit
  • NMDA
  • neurodegeneration
  • Non-human Primates
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire